criteria for semaglutide Hype or Hope: Evidence-based Review in Diabesity CLINICAL AND SOCIODEMOGRAPHIC HETEROGENEITY FOR

References [1] A, Lene Jensen , et al

Remember : it is not just about losing weight

July 31 Product: Johnson & Johnsons Darzalex Faspro Indication : Multiple myeloma Johnson & Johnson picked up another indication for its Darzalex Faspro Wednesday as the FDA approved the therapy, in combination with bortezomib, lenalidomide and dexamethasone, to treat newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant

The Gold Rush Economics While the FDA works through its regulatory sequence, the money has already made up its mind

These warnings raise important questions about the overall safety of this class of drugs and whether doctors and patients have been adequately informed about the risks

A secondary analysis of these findings discovered that semaglutide significantly improves heart failure symptoms in both males and females, leading to greater weight loss in the latter